Tibra Equities Europe’s AtriCure ATRC Stock Holding History

Tibra Equities Europe’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,800	Closed	-$370K	–	255
2019 Q1	$370K	Buy	+13,800	New	+$419K	0.04%	301

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Tibra Equities Europe's ATRC Position: Q2 2019 in Review

Tibra Equities Europe sold out of AtriCure (ATRC) in Q2 2019, closing a stake of 13,800 shares — an estimated $370K sold.

Tibra Equities Europe first reported a position in ATRC in Q1 2019 and held it in 1 quarter. The position peaked at $370K in Q1 2019. 145 funds tracked by Wall St. Rank hold ATRC as of Q2 2019.

Tibra Equities Europe reported no remaining AtriCure position as of Q2 2019 after selling out during the quarter.
Tibra Equities Europe sold 13,800 AtriCure shares in Q2 2019, an estimated $370K.
Tibra Equities Europe first reported a position in AtriCure in Q1 2019 and held it in 1 quarter.
Tibra Equities Europe's AtriCure position peaked at $370K in Q1 2019.
145 funds tracked by Wall St. Rank held AtriCure as of Q2 2019.

Based on Tibra Equities Europe's 13F filing for Q2 2019, filed 1 Aug 2019.